Literature DB >> 31246531

The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.

Padma Sheila Rajagopal1, Daniel V T Catenacci1, Olufunmilayo I Olopade1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31246531      PMCID： PMC6698918          DOI： 10.1200/JCO.19.00160

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  Impact of Payer Constraints on Access to Genetic Testing.

Authors:  Pat Whitworth; Peter Beitsch; Christopher Arnell; Hannah C Cox; Krystal Brown; John Kidd; Johnathan M Lancaster
Journal:  J Oncol Pract       Date:  2016-10-23       Impact factor: 3.840

2.  Genetics in clinical cancer care--the future is now.

Authors:  O I Olopade
Journal:  N Engl J Med       Date:  1996-11-07       Impact factor: 91.245

3.  Advances in Genetic Testing in Patients With Breast Cancer, High-Quality Decision Making, and Responsible Resource Allocation.

Authors:  Kara J Milliron; Jennifer J Griggs
Journal:  J Clin Oncol       Date:  2018-12-07       Impact factor: 44.544

4.  National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.

Authors:  Christopher P Childers; Kimberly K Childers; Melinda Maggard-Gibbons; James Macinko
Journal:  J Clin Oncol       Date:  2017-08-18       Impact factor: 44.544

5.  Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.

Authors:  Ashley Stuckey; Terri Febbraro; Jessica Laprise; Jennifer S Wilbur; Vrishali Lopes; Katina Robison
Journal:  Am J Clin Oncol       Date:  2016-08       Impact factor: 2.339

6.  Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.

Authors:  Steven J Katz; Irina Bondarenko; Kevin C Ward; Ann S Hamilton; Monica Morrow; Allison W Kurian; Timothy P Hofer
Journal:  JAMA Surg       Date:  2018-10-01       Impact factor: 14.766

7.  Tumor genome analysis includes germline genome: are we ready for surprises?

Authors:  Daniel V T Catenacci; Andrea L Amico; Sarah M Nielsen; Daniel M Geynisman; Brittany Rambo; George B Carey; Cassandra Gulden; Jim Fackenthal; Robert D Marsh; Hedy L Kindler; Olufunmilayo I Olopade
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

8.  Inherited Breast Cancer in Nigerian Women.

Authors:  Yonglan Zheng; Tom Walsh; Suleyman Gulsuner; Silvia Casadei; Ming K Lee; Temidayo O Ogundiran; Adeyinka Ademola; Adeyinka G Falusi; Clement A Adebamowo; Abideen O Oluwasola; Adewumi Adeoye; Abayomi Odetunde; Chinedum P Babalola; Oladosu A Ojengbede; Stella Odedina; Imaria Anetor; Shengfeng Wang; Dezheng Huo; Toshio F Yoshimatsu; Jing Zhang; Gabriela E S Felix; Mary-Claire King; Olufunmilayo I Olopade
Journal:  J Clin Oncol       Date:  2018-08-21       Impact factor: 50.717

9.  Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

Authors:  Peter D Beitsch; Pat W Whitworth; Kevin Hughes; Rakesh Patel; Barry Rosen; Gia Compagnoni; Paul Baron; Rache Simmons; Linda Ann Smith; Ian Grady; Michael Kinney; Cynara Coomer; Karen Barbosa; Dennis R Holmes; Eric Brown; Linsey Gold; Patricia Clark; Lee Riley; Samuel Lyons; Antonio Ruiz; Sadia Kahn; Heather MacDonald; Lisa Curcio; Mary Kay Hardwick; Shan Yang; Ed D Esplin; Robert L Nussbaum
Journal:  J Clin Oncol       Date:  2018-12-07       Impact factor: 44.544
  9 in total
  4 in total

1.  Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.

Authors:  Pat W Whitworth; Peter D Beitsch; Rakesh Patel; Barry Rosen; Gia Compagnoni; Paul L Baron; Rache Simmons; Eric A Brown; Linsey Gold; Dennis Holmes; Linda Ann Smith; Michael Kinney; Ian Grady; Patricia Clark; Karen Barbosa; Samuel Lyons; Lee Riley; Cynara Coomer; Lisa Curcio; Antonio Ruiz; Sadia Khan; Heather MacDonald; Kevin Hughes; Mary Kay Hardwick; Brandie Heald; Sandra B Munro; Sarah M Nielsen; Edward D Esplin
Journal:  JAMA Netw Open       Date:  2022-09-01

2.  Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.

Authors:  Jenny Lin; Ravi N Sharaf; Rachel Saganty; Danyal Ahsan; Julia Feit; Andrea Khoury; Hannah Bergeron; Eloise Chapman-Davis; Evelyn Cantillo; Kevin Holcomb; Stephanie V Blank; Ying Liu; Charlene Thomas; Paul J Christos; Drew N Wright; Steven Lipkin; Kenneth Offit; Melissa K Frey
Journal:  Gynecol Oncol       Date:  2021-05-19       Impact factor: 5.304

3.  Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.

Authors:  Siddhartha Yadav; Chunling Hu; Steven N Hart; Nicholas Boddicker; Eric C Polley; Jie Na; Rohan Gnanaolivu; Kun Y Lee; Tricia Lindstrom; Sebastian Armasu; Patrick Fitz-Gibbon; Karthik Ghosh; Daniela L Stan; Sandhya Pruthi; Lonzetta Neal; Nicole Sandhu; Deborah J Rhodes; Christine Klassen; Prema P Peethambaram; Tufia C Haddad; Janet E Olson; Tanya L Hoskin; Matthew P Goetz; Susan M Domchek; Judy C Boughey; Kathryn J Ruddy; Fergus J Couch
Journal:  J Clin Oncol       Date:  2020-03-03       Impact factor: 44.544

4.  Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.

Authors:  Julie O Culver; Yael Freiberg; Charité Ricker; Jacob G Comeaux; Emmeline Y Chang; Victoria Banerjee; Duveen Sturgeon; Ilana Solomon; Josie Kagey; Mariana G Dobre; Joseph Carey; Azadeh Carr; Stephanie Cho; Janice Lu; Irene M Kang; Ketan Patel; Alicia Terando; Jason C Ye; Ming Li; Caryn Lerman; Darcy Spicer; Maria Nelson
Journal:  Ann Surg Oncol       Date:  2022-09-26       Impact factor: 4.339
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.